CLINICAL_TRIALS
ClinicalTrials.gov record update
68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05543317
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:17.990895+00:00
- Published At
- 2023-02-27T00:00:00+00:00
- Record Updated At
- 2023-02-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Tumor, Solid", "Positron-Emission Tomography"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-02-27"- protocolSection.identificationModule.nctId
"NCT05543317"- protocolSection.identificationModule.officialTitle
"68Ga-FAPI-RGD PET/CT for Dual Integrin \u03b1v\u03b23 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.